Open AccessPyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
Author(s) -
Ronnatrai Rueangweerayut,
Aung Pyae Phyo,
Chirapong Uthaisin,
Poravuth Yi,
Trần Quang Bình,
Halidou Tinto,
Louis K. Pénali,
Neena Valecha,
g T Tien,
Salim Abdulla,
Isabelle Borghini-Fuhrer,
Stephan Duparc,
Chang-Sik Shin,
Lawrence Fleckenstein
Publication year - 2012
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1007125
Subject(s) - artesunate , medicine , mefloquine , artemisinin , population , malaria , plasmodium falciparum , pharmacology , immunology , environmental health
Pyronaridine-artesunate is an artemisinin-based combination therapy under evaluation for the treatment of Plasmodium falciparum and P. vivax malaria.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom